If you are asking whether 7-OH is banned, here is the straight answer: as of October 05, 2026, 7-OH is not federally scheduled under the Controlled Substances Act, but concentrated 7-OH products are unlawful as foods or dietary supplements under FDA policy and state rules can make possession or sale illegal. Your state matters, and federal scheduling is still pending.
7-OH, short for 7-hydroxymitragynine, occurs naturally in small amounts in kratom leaf. The FDA says its current enforcement focus is products with added or enhanced 7-OH, including tablets, gummies, drink mixes, and shots.
Is there a federal 7OH ban?
There is no completed federal Controlled Substances Act ban listed in the supplied material as of October 05, 2026. The FDA kratom guidance explains the agency’s position on kratom products, while the state-law tracker reports that the FDA recommended Schedule I control for concentrated 7-OH products on July 29, 2025 and that a DEA temporary-scheduling notice was published July 6, 2026.
That does not make concentrated 7-OH food or supplement products federally lawful. The FDA says added or enhanced 7-OH cannot lawfully be used in conventional foods or dietary supplements, and it announced a December 2, 2025 seizure of approximately 73,000 concentrated 7-OH units from three Missouri firms. The seized formats included liquid shots and tablets.
When would a federal 7OH ban start?
There is no federal scheduling start date in the supplied material. The tracker says no temporary scheduling order had issued by October 2026, so there is no nationwide possession-ban date to count on. Before you rely on an older post, check the DEA and the FDA 7-OH update for a new order or enforcement announcement.
Which states ban kratom or its alkaloids?
The supplied October 2026 state tracker lists nine states as fully banning kratom: Alabama, Arkansas, Connecticut, Indiana, Louisiana, Massachusetts, Tennessee, Vermont, and Wisconsin. In those states, possession, sale, and manufacture are generally criminal offenses, although the statute and penalty vary.
| State | Status reported | Key date or rule |
|---|---|---|
| Alabama | Mitragynine and 7-OH listed in Schedule I | Alabama Code § 20-2-23; reported in place since 2016 |
| Arkansas | Kratom alkaloids listed in Schedule I | Reported since 2016 |
| Connecticut | Kratom and derivatives, including 7-OH, in Schedule I | Regulations approved in 2026 |
| Indiana | Kratom alkaloids covered by synthetic-drug law | Indiana Code § 35-31.5-2-321 |
| Louisiana | Full kratom ban | SB 154, Act 41; effective August 2025 |
| Massachusetts | Temporary Schedule I placement | Emergency regulation reported August 2026 |
| Tennessee | Full kratom ban | HB1649/SB1656, Public Chapter 950; effective July 1, 2026 |
| Vermont | Schedule I treatment | Reported state classification |
| Wisconsin | Kratom alkaloids in Schedule I | Wisconsin Statute 961.14 |
Rhode Island is reported to have moved the other way: its Kratom Act took effect April 1, 2026 and allows regulated sales to adults 21 and older. Rules can shift quickly, so check your state health department or law-enforcement agency before you travel with or buy a kratom product.
What rules apply where kratom is regulated?
More than 30 states are reported to use some form of Kratom Consumer Protection Act framework. Common rules include a 21-plus age limit, ingredient and alkaloid labeling, batch information, testing requirements, limits on 7-OH concentration, and restrictions on synthetic alkaloid additives. Utah is specifically reported to require product registration before sale.
For a whole-leaf product, start with the label: look for the product name, batch or lot, and alkaloid information required where it is sold. Whole-leaf strain names can describe a product category, as in this White Thai Kratom guide or this White Vein Kratom overview, but a strain name does not decide your state’s 7-OH rule.
What could change next?
Federal scheduling of concentrated 7-OH is the main pending change described in the supplied material. At the state level, the tracker reports pending or introduced 2026 measures in South Carolina, Washington, Michigan, Illinois, Kansas, West Virginia, Wyoming, and Maryland. New York lawmakers also passed a proposal in June 2026 that would prohibit sale of 7-OH products; the supplied report says New York already had a 21-plus kratom sales rule and ingredient-list requirement.
Does 7-OH show up on a drug test?
It depends on the panel and the laboratory method. The supplied CDC report says identification of kratom in toxicology is method-dependent, so ask the testing program or laboratory which analytes its test includes instead of assuming a standard panel answers the question.
What withdrawal symptoms are reported with 7-OH?
The FDA lists reported withdrawal symptoms with 7-OH products as restlessness, body aches, fatigue, irritability, and cold sweats. Its consumer update also lists addiction, anxiety, depression, gastrointestinal distress, insomnia, and seizures among reported harmful effects. The National Institute on Drug Abuse says research is still developing and that kratom-related withdrawal may occur after regular use.
If someone is unresponsive, call 911. For a suspected bad reaction, the FDA directs people to Poison Help at 1-800-222-1222.
Before you rely on a 7OH ban update
- Confirm whether the product is whole-leaf kratom or a concentrated 7-OH product.
- Check your state health or law-enforcement agency for current possession and retail rules.
- Check the DEA for any final scheduling order and the FDA for current enforcement notices.
- Ask the test administrator which substances its panel can identify if testing is your concern.
This page is general information, not legal advice.
Disclosure: This page contains no product recommendations or purchase links.
By UltimateKratom.com Research Desk
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
Leave a Reply